4-Hydroxynonenal BSA Conjugate

4-Hydroxynonenal (4-HNE) BSA Conjugate is a widely used biomarker for lipid peroxidation and oxidative stress in the brain. 4-HNE is derived from omega-6 fatty acid oxidation and forms stable adducts with nucleophilic amino acids, disrupting protein function and cellular signaling. In neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, 4-HNE-modified proteins accumulate in affected brain regions, contributing to synaptic dysfunction, mitochondrial damage, and chronic inflammation. 4-HNE also activates pro-apoptotic pathways and impairs proteasomal degradation, exacerbating neuronal loss. The BSA conjugate enables precise quantification of 4-HNE adducts in tissue and serum samples, facilitating biomarker discovery and therapeutic evaluation in oxidative stress-driven neurodegeneration.

4-Hydroxynonenal BSA Conjugate, 4-Hydroxy Nonenal (4-HNE) BSA Conjugate, 4-Hydroxy Nonenal BSA Conjugate, 4-HNE BSA Conjugate, 4-Hydroxy Nonenal-BSA Conjugate, 4-Hydroxy Nonenal (BSA) Conjugate, MG-BSA, MG-BSA Conjugate, 4-Hydroxy Nonenal-modified BSA, 4-Hydroxy Nonenal Bovine Serum Albumin Conjugate, 4-Hydroxy Nonenal-Bovine Serum Albumin Conjugate, 4-Hydroxy Nonenal (Bovine Serum Albumin) Conjugate, 4-Hydroxy Nonenal-modified Bovine Serum Albumin, 4-Hydroxy Nonenal-bovine serum albumin, HNE BSA Conjugate, 4-hydroxy-2-nonenal BSA Conjugate